Cryoablation for Monomorphic Ventricular Tachycardia

Description

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

Conditions

Sustained VT

Study Overview

Study Details

Study overview

The objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)

Cryoablation for Monomorphic Ventricular Tachycardia IDE Study: EFS and Pivotal

Cryoablation for Monomorphic Ventricular Tachycardia

Condition
Sustained VT
Intervention / Treatment

-

Contacts and Locations

Phoenix

Banner University Medical Center Phoenix, Phoenix, Arizona, United States, 85006

San Francisco

University of California San Francisco, San Francisco, California, United States, 94143

New York

Icahn School of Medicine at Mount Sinai, New York, New York, United States, 10029

Nashville

Vanderbilt University Medical Center, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Adagio Medical,

    Study Record Dates

    2026-03-30